Leukemia
Leukemia
Country: Unknown
Publisher: Unknown
Publication Period: Unknown
913
Papers in Database
Journal Information
Publication Details
Additional Information
Subject Term Count: 1
Last Updated: Aug 05, 2025
Recent Papers
View All 913 PapersClonal medicine targeting DNA damage response eradicates leukemia.
Toma MM, Karami A, Nieborowska-Skorska M, Chirtala KN, Pepek M, Hadzijusufovic E, Stoklosa T, Valen…
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE …
Jabbour E, Apperley J, Cortes J, Rea D, Deininger M, Abruzzese E, Chuah C, DeAngelo DJ, Hochhaus A,…
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression.
Li Y, Mendoza-Castrejon J, Patel RM, Casey EB, Denby E, Bryder D, Magee JA.
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patte…
Knauft J, Schenk T, Ernst T, Schnetzke U, Hochhaus A, La Rosée P, Birndt S.
Prognostic impact of CEBPA mutational subgroups in adult AML.
Georgi JA, Stasik S, Kramer M, Meggendorfer M, Röllig C, Haferlach T, Valk P, Linch D, Herold T, Du…
A C/ebpα isoform specific differentiation program in immortalized myelocytes.
Garcia-Cuellar MP, Akan S, Slany RK.
Activation of distinct inflammatory pathways in subgroups of LR-MDS.
Schneider M, Rolfs C, Trumpp M, Winter S, Fischer L, Richter M, Menger V, Nenoff K, Grieb N, Metzel…
Age-related decline in LEPR<sup>+</sup> hematopoietic stem cell function.
Trinh T, Ropa J, Cooper S, Aljoufi A, Sinn A, Capitano M, Broxmeyer HE, Kaplan MH.
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.
Zander T, Pabst T, Schär S, Aebi S, Mey U, Novak U, Lerch E, Rhyner Agocs G, Goede J, Maniecka Z, H…
AML classification in the year 2023: How to avoid a Babylonian confusion of languages.
Huber S, Baer C, Hutter S, Dicker F, Meggendorfer M, Pohlkamp C, Kern W, Haferlach T, Haferlach C, …